Skip to main content

Sight Sciences, Inc.

SGHT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001531177

In the last 90 days, Sight Sciences, Inc. insiders filed 0 open-market purchases and 6 sales; 112 institutions reported holding it in 13F filings for Q2 2026, worth $118.5M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Sight Sciences, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of SGHT: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders83177−5
Shares22.7M64.1K20.7M−1.87M (−8.3%)
Value$81.7M$233.3K$49.6M−$31.9M (−39.2%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held Sight Sciences, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to SGHT in Q1 2025
InstitutionSharesValue% of portfolio
Nuveen, LLC64,103$153.8K0.00%
AQR Capital Management LLC53,329$128.0K0.00%
Foster Victor Wealth Advisors, LLC35,895$85.4K0.01%
Engineers Gate Manager LP18,244$43.8K0.00%
JustInvest LLC11,435$27.4K0.00%
Coldstream Capital Management Inc260$6240.00%
Nisa Investment Advisors, LLC225$5400.00%
True Wealth Design, LLC169$4060.00%
The PNC Financial Services Group, Inc.86$2060.00%
Gotham Asset Management, LLC95,889––

Sold out (15)

Institutions that held Sight Sciences, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Not filed for Q1 2025 yet (1)

Institutions that held Sight Sciences, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SGHT in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC64,103$233.3K